NO991678D0 - Sulfonamid-substituerte asparaginsyre-interleukin-1<beta>-omdannelsesenzym-inhibitorer - Google Patents
Sulfonamid-substituerte asparaginsyre-interleukin-1<beta>-omdannelsesenzym-inhibitorerInfo
- Publication number
- NO991678D0 NO991678D0 NO991678A NO991678A NO991678D0 NO 991678 D0 NO991678 D0 NO 991678D0 NO 991678 A NO991678 A NO 991678A NO 991678 A NO991678 A NO 991678A NO 991678 D0 NO991678 D0 NO 991678D0
- Authority
- NO
- Norway
- Prior art keywords
- pct
- beta
- interleukin
- sulfonamide
- aspartic acid
- Prior art date
Links
- 102000000589 Interleukin-1 Human genes 0.000 title 1
- 108010002352 Interleukin-1 Proteins 0.000 title 1
- 235000003704 aspartic acid Nutrition 0.000 title 1
- 150000001509 aspartic acid derivatives Chemical class 0.000 title 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 title 1
- 238000006243 chemical reaction Methods 0.000 title 1
- 239000002532 enzyme inhibitor Substances 0.000 title 1
- 108090000426 Caspase-1 Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000004429 Bacillary Dysentery Diseases 0.000 abstract 1
- 206010063837 Reperfusion injury Diseases 0.000 abstract 1
- 206010040070 Septic Shock Diseases 0.000 abstract 1
- 206010040550 Shigella infections Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000036303 septic shock Effects 0.000 abstract 1
- 201000005113 shigellosis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/12—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
- C07C323/67—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfonamide groups, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2832396P | 1996-10-11 | 1996-10-11 | |
| PCT/US1997/018406 WO1998016504A2 (en) | 1996-10-11 | 1997-10-09 | SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO991678D0 true NO991678D0 (no) | 1999-04-09 |
| NO991678L NO991678L (no) | 1999-04-12 |
| NO315042B1 NO315042B1 (no) | 2003-06-30 |
Family
ID=21842812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19991678A NO315042B1 (no) | 1996-10-11 | 1999-04-09 | Sulfonamid-substituerte asparaginsyre-interleukin-1<beta>- omdannelsesenzym-inhibitorer, anvendelse derav og farmasöytiske preparaterinneholdende disse forbindelser |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6083981A (no) |
| EP (1) | EP0932600B1 (no) |
| JP (1) | JP2001502330A (no) |
| KR (1) | KR20000049050A (no) |
| AT (1) | ATE317381T1 (no) |
| AU (1) | AU742746B2 (no) |
| BR (1) | BR9713314A (no) |
| CA (1) | CA2268103A1 (no) |
| DE (1) | DE69735230D1 (no) |
| IL (1) | IL129124A0 (no) |
| NO (1) | NO315042B1 (no) |
| NZ (1) | NZ334887A (no) |
| PL (1) | PL332704A1 (no) |
| WO (1) | WO1998016504A2 (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1800176A (zh) * | 2000-12-13 | 2006-07-12 | 惠氏 | β淀粉样蛋白产生的杂环磺酰胺类抑制剂 |
| EP1392280A4 (en) * | 2001-05-10 | 2005-11-30 | Warner Lambert Co | ARYLSULFONAMIDE ETHERS AND METHODS OF USE THEREOF |
| JP4502580B2 (ja) * | 2001-05-16 | 2010-07-14 | イエダ リサーチ アンド ディベロップメント カンパニー リミテッド | 敗血症の治療または予防のためのil−18阻害剤の使用 |
| AU2005249503B2 (en) | 2003-11-10 | 2011-08-25 | Vertex Pharmaceuticals Incorporated | ICE inhibitors for the treatment of autoinflammatory diseases |
| EP2374792A1 (en) * | 2004-03-11 | 2011-10-12 | Elan Pharmaceuticals Inc. | N-substituted benzene sulfonamides |
| CN102362867A (zh) | 2004-05-15 | 2012-02-29 | 沃泰克斯药物股份有限公司 | 使用ice抑制剂治疗癫痫发作 |
| EP1752159A4 (en) * | 2004-05-17 | 2009-07-01 | Univ Keio | MEDICAL COMPOSITION AND THERAPEUTIC PROCEDURE |
| CA2963784A1 (en) | 2007-06-08 | 2008-12-18 | Mannkind Corporation | Ire-1.alpha. inhibitors |
| JP2010535167A (ja) | 2007-08-03 | 2010-11-18 | サノフィ−アベンティス | カスパーゼイメージングプローブ |
| US8524748B2 (en) | 2008-10-08 | 2013-09-03 | Panmira Pharmaceuticals, Llc | Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors |
| EP2635906A4 (en) | 2010-11-05 | 2014-04-02 | Univ Brandeis | Ice inhibiting compounds and uses thereof |
| US9956260B1 (en) | 2011-07-22 | 2018-05-01 | The J. David Gladstone Institutes | Treatment of HIV-1 infection and AIDS |
| EP2848696A1 (en) | 2013-09-13 | 2015-03-18 | Sanofi-Aventis Deutschland GmbH | Caspase-1 imaging probes |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6204261B1 (en) * | 1995-12-20 | 2001-03-20 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β Converting enzyme inhibitors |
| DE4102024A1 (de) * | 1991-01-24 | 1992-07-30 | Thomae Gmbh Dr K | Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| EP0519748B1 (en) * | 1991-06-21 | 1998-09-02 | Merck & Co. Inc. | Peptidyl derivatives as inhibitors of interleukin-1B converting enzyme |
| GB9200420D0 (en) * | 1992-01-09 | 1992-02-26 | James Black Foundation The Lim | Amino acid derivatives |
| WO1995026958A1 (en) * | 1994-03-31 | 1995-10-12 | Sanofi Winthrop, Inc. | Pyrimidinyl derivatives as interleukin inhibitors |
| US5552400A (en) * | 1994-06-08 | 1996-09-03 | Sterling Winthrop Inc. | Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors |
| US5716929A (en) * | 1994-06-17 | 1998-02-10 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1β converting enzyme |
| US5756466A (en) * | 1994-06-17 | 1998-05-26 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1β converting enzyme |
-
1997
- 1997-10-09 CA CA002268103A patent/CA2268103A1/en not_active Abandoned
- 1997-10-09 DE DE69735230T patent/DE69735230D1/de not_active Expired - Lifetime
- 1997-10-09 WO PCT/US1997/018406 patent/WO1998016504A2/en not_active Ceased
- 1997-10-09 IL IL12912497A patent/IL129124A0/xx unknown
- 1997-10-09 US US09/284,425 patent/US6083981A/en not_active Expired - Fee Related
- 1997-10-09 JP JP10518482A patent/JP2001502330A/ja not_active Abandoned
- 1997-10-09 NZ NZ334887A patent/NZ334887A/xx unknown
- 1997-10-09 EP EP97910909A patent/EP0932600B1/en not_active Expired - Lifetime
- 1997-10-09 AU AU48172/97A patent/AU742746B2/en not_active Ceased
- 1997-10-09 KR KR1019990703119A patent/KR20000049050A/ko not_active Ceased
- 1997-10-09 PL PL97332704A patent/PL332704A1/xx unknown
- 1997-10-09 BR BR9713314-0A patent/BR9713314A/pt not_active Application Discontinuation
- 1997-10-09 AT AT97910909T patent/ATE317381T1/de not_active IP Right Cessation
-
1999
- 1999-04-09 NO NO19991678A patent/NO315042B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU742746B2 (en) | 2002-01-10 |
| PL332704A1 (en) | 1999-09-27 |
| EP0932600A2 (en) | 1999-08-04 |
| WO1998016504A2 (en) | 1998-04-23 |
| BR9713314A (pt) | 2000-01-25 |
| JP2001502330A (ja) | 2001-02-20 |
| ATE317381T1 (de) | 2006-02-15 |
| EP0932600B1 (en) | 2006-02-08 |
| NZ334887A (en) | 2000-09-29 |
| DE69735230D1 (de) | 2006-04-20 |
| IL129124A0 (en) | 2000-02-17 |
| NO315042B1 (no) | 2003-06-30 |
| CA2268103A1 (en) | 1998-04-23 |
| KR20000049050A (ko) | 2000-07-25 |
| WO1998016504A3 (en) | 1998-06-25 |
| US6083981A (en) | 2000-07-04 |
| AU4817297A (en) | 1998-05-11 |
| NO991678L (no) | 1999-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO991674D0 (no) | Interleukin-1<Beta>omdannelsesenzym-inhibitor-sulfonamider | |
| PT1049703E (pt) | Aldeido do acido n-¬2-(5-benziloxicarbonilamino-6-oxo-2-(4-fluorofenil)-1,6-di-hidro-1-pirimidinil)acetoxil|-l-aspartico como inibidor da enzima de conversao da interleucina-1beta in vivo | |
| NO991678D0 (no) | Sulfonamid-substituerte asparaginsyre-interleukin-1<beta>-omdannelsesenzym-inhibitorer | |
| ATE240103T1 (de) | Intermediaires des produits definitifs de glycosylation avancee et inhibition des produits age post-amadori | |
| EA200400648A1 (ru) | N, n'-замещенные производные 1,3-диамино-2-гидроксипропана | |
| MA26861A1 (fr) | Inhibiteurs non peptidiques de la liaison cellulaire sous la dependance de vla-4 utiles dans le traitement des maladies inflammatoires, auto-immunes et respiratoires | |
| PT752987E (pt) | Derivados de pirimidinilo como inibidores da interleucina | |
| ATE310011T1 (de) | Inhibitoren des interleukin-1-beta konvertierenden enzyms | |
| MA27781A1 (fr) | 3-fluoro-piperidines comme antagonistes de nmda/nr2b. | |
| BR9911010A (pt) | Inibidores de sucinamida de enzima de conversão da interleucina-1beta | |
| ATE363474T1 (de) | Benzimidazole zur behandlung sexueller fehlfunktionen | |
| BR9503572A (pt) | Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença | |
| WO2002089749A3 (en) | Arylsulfonamide ethers, and methods of use thereof | |
| WO2001091796A8 (en) | Methods, compounds and compositions for treating gout | |
| EA200100297A1 (ru) | Моногидрат гидробромида элетриптана | |
| BG107051A (en) | Method for the preparation of citalopram | |
| DK1165491T3 (da) | LTA4-hydrolase-inhibitorer | |
| DE60204014D1 (de) | Chlormethylierung von thiophene | |
| BR0015482A (pt) | Antagonistas de difenil leucotrieno de heterociclo substituìdo | |
| BR9612000A (pt) | Naftil glioxamidas como inibidores de spla; ' |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |